Dualsystems Biotech AG is specialises in elucidating protein-protein interactions in the living cells especially at the cell membrane. Dualsystems is a privately held service provider company based in Schlieren (Zurich), Switzerland. Our clients range from big pharma, biotech to academia. We focus on our conceptually new technology for target deconvolution on the Ligand-Receptor Capture LRC-TriCEPS platform. The LRC-TriCEPS technology is able to identify the unknown targets, off-targets, receptors of your orphan ligand on the living cells and is an excellent tool to investigate the binding partners of your drug candidates.
Following orphan ligands can be used: small molecules, peptides, proteins, antibodies, viruses.